PhD (Medicine), Shinshu University (Japan)

Medicine

Gastroenterology, Gastroenterology

2010, Shinshu University Graduate School of Medicine

2002, Niigata University School of Medicine

Higher Responsiveness for Women, High Transaminase Levels, and Fat Percentage to Pemafibrate Treatment for NAFLD
Iwadare T, Kimura T, Kunimoto H, Tanaka N, Wakabayashi SI, Yamazaki T, Okumura T, Kobayashi H, Yamashita Y, Sugiura A, Joshita S, Umemura T
BIOMEDICINES, 10(11), Nov. 2022

Circulating thrombospondin 2 levels reflect fibrosis severity and disease activity in HCV-infected patients
Iwadare T, Kimura T, Tanaka N, Yamazaki T, Wakabayashi SI, Okumura T, Kobayashi H, Yamashita Y, Pydi SP, Nakajima T, Iwaya M, Sugiura A, Joshita S, Uehara T
Sci Rep, 12(1), 18900, Nov. 2022

Toward the accumulation of evidence for a novel high-sensitivity hepatitis B core-related antigen assay in patients with hepatitis B virus infection
Joshita, S.
Hepatol Res, 52(9), 743-744, Sep. 2022

Quantitative changes of lipoprotein(a) in chronic hepatitis C patients achieving a sustained virological response by direct-acting antivirals
Okumura T, Joshita S, Sugiura A, Ota M, Umemura T
Clin Res Hepatol Gastroenterol, 46(8), 102011, Aug. 2022

The levels of IL-1beta and soluble IL-1 receptors in patients with IgG4-related periaortitis/periarteritis
Ashihara N, Ota M, Fujinaga Y, Ozawa M, Kuraishi Y, Watanabe T, Hamano H, Joshita S, Kawa S, Umemura T
Adv Med Sci, 67(2), 257-261, Jul. 2022

The aryl hydrocarbon receptor instructs the immunomodulatory profile of a subset of Clec4a4(+) eosinophils unique to the small intestine
Wang WL, Kasamatsu J, Joshita S, Gilfillan S, Di Luccia B, Panda SK, Kim DH, Desai P, Bando JK, Huang SC, Yomogida K, Hoshino H, Fukushima M, Jacobsen EA, Van Dyken SJ, Ruedl C, Cella M, Colonna M
Proc Natl Acad Sci U S A, 119(23), e2204557119, Jun. 2022

Clinical practice guidelines for autoimmune hepatitis
Ohira H, Takahashi A, Zeniya M, Abe M, Arinaga-Hino T, Joshita S, Takaki A, Nakamoto N, Kang JH, Suzuki Y, Sogo T, Inui A, Koike K, Harada K, Nakamoto Y, Kondo Y, Genda T, Tsuneyama K, Matsui T, Tanaka A:
Hepatol Res, 52(7), 571-585, May 2022

Risk factors for relapse of autoimmune hepatitis in Japan: A nationwide survey
Takahashi A, Ohira H, Abe K, Zeniya M, Abe M, Arinaga-Hino T, Nakamoto N, Takaki A, Kang JH, Joshita S, Suzuki Y, Koike K, Inui A, Tanaka A, Japan Autoimmune Hepatitis Study G
Hepatol Res, 52(7), 597-602, Apr. 2022

IL-33 signaling in sensory neurons promotes dry skin itch
Trier AM, Mack MR, Fredman A, Tamari M, Ver Heul AM, Zhao Y, Guo CJ, Avraham O, Ford ZK, Oetjen LK, Feng J, Dehner C, Coble D, Badic A, Joshita S, Kubo M, Gereau RWt, Alexander-Brett J, Cavalli V, Davidson S, Hu H, Liu Q, Kim BS
J Allergy Clin Immunol, 149(4), 1473-1480, Apr. 2022

Quantitative Changes in Neutralizing Antibody Before and After SARS-CoV-2 Vaccination
JOSHITA Satoru
The Shinshu Medical Journal, 70(1), 47-51, Feb. 2022

2-Step PLT16-AST44 method: Simplified liver fibrosis detection system in patients with non-alcoholic fatty liver disease
Fujimori N, Kimura T, Tanaka N, Yamazaki T, Okumura T, Kobayashi H, Wakabayashi SI, Yamashita Y, Sugiura A, Pham J, Pydi SP, Sano K, Joshita S, Umemura T
Hepatol Res, 52(4), 352-363, Jan. 2022

A Case of Liver Metastasis in Primary Renal Cell Carcinoma Diagnosed by Hepatectomy after 9 Years of Follow-up of Cystic Liver Lesion
SHIMIZU Yuki, SUGIURA Ayumi, JOSHITA Satoru, KOBAYASHI Hiroyuki, WAKABAYASHI Shun-ichi, YAMASHITA Yuki, YAMAZAKI Tomoo, UEHARA Takeshi, SHIMIZU Akira, SOEJIMA Yuji,UMEMURA Takeji
The Shinshu Medical Journal, 69(4), 209-215, Aug. 2021

Adult Case of Acute Hepatitis Associated with Primary Cytomegalovirus Infection in Remission Phase of Crohn's Disease
YAMAZAKI Tomoo, JOSHITA Satoru, OHNO Kazuyuki, SUGA Tomoaki, KOBAYASHI Hiroyuki, WAKABAYASHI Shun-ichi, YAMASHITA Yuki, SUGIURA Ayumi, UMEMURA Takeji
The Shinshu Medical Journal, 69(3), 127-133, Jun. 2021

Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease
Wakabayashi SI, Joshita S (CA), Kimura K, et al.
PLOS ONE, 16(4), e0249435, 01 Apr. 2021, Refereed

Primary hepatic extranodal marginal zone lymphoma of muco-sa-associated lymphoid tissue in a patient with chronic hepati-tis B virus infection: Case report and summary of the literature
Yamashita Y, Joshita S (CA), Kobayashi H, et al.
Medicina, 57, 280, 18 Mar. 2021, Refereed

Intestinal Obstruction Due to Mesenteric Inflammatory Veno-occlusive Disease: A Case Report and Summary of the Literature
Kobayashi H, Joshita S (CA), Nozawa Y, et al.
shinshu med J, 69(3), 141-147, 03 Feb. 2021, Refereed

An Autopsy Case of Primary Biliary Cholangitis with Histological Submassive Hepatic Necrosis Caused by Acute Hepatitis E Virus Infection
Koyama M, Yamazaki T, Joshita S (3rd), et al.
Intern Med, in press, 01 Feb. 2021, Refereed

Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLD
Kimura T, Tanaka N, Joshita S (8th), et al.
Liver Int., 41(3), 505-514, 20 Jan. 2021, Refereed

The ursodeoxycholic acid response score predicts pathological features in primary biliary cholangitis
Kawata K, Joshita S (2nd), Shimoda S, et al.
Hepatol Res., 51(1), 80-89, 01 Jan. 2021, Refereed

Relationship of early acute complications and insertion site in push method percutaneous endoscopic gastrostomy
Suzuki H (FA), Joshita S (FA), Nagaya T (CA), et al.
Sci Rep, 10(1), 20551, 25 Nov. 2020, Refereed

Clinical utility of steatohepatitis-related FibroScan-aspartate aminotransferase score for predicting hepatocellular carcinoma in chronic hepatitis C virus patients achieving a sustained virological response by direct-acting antivirals
Joshita S (FA), Umemura T (CA).
Alimentary Pharmacology & Therapeutics., 52(7), 1222-1223, 01 Oct. 2020, Refereed

A case report of pancreatic panniculitis due to acute pancreatitis with intraductal papillary mucinous neoplasm
Yamashita Y (FA), Joshita S (CA), Ito T, Maruyama M, Wada S, Umemura T.
BMC Gastroenterol., 20(1), 286, 24 Aug. 2020, Refereed

Clinical impact of normal alanine aminotransferase on direct‐acting antiviral outcome in patients with chronic hepatitis C virus infection
Joshita S (FA), Sugiura A (FA), Umemura T (CA), et al.
JGH Open., 4, 574-581, 01 Aug. 2020, Refereed

A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitis
Yagi M, Matsumoto K, Joshita S (15th), et al.
Liver Int., 40(8), 1926-1933, 01 Aug. 2020, Refereed

Polymorphism at rs9264942 is associated with HLA-C expression and inflammatory bowel disease in the Japanese
Suzuki H (FA), Joshita S (CA), Hirayama H, et al.
Sci Rep., 10(1), 12424, 24 Jul. 2020, Refereed

Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis.
Joshita S (FA/CA), Yamashita Y, Sugiura A, et al.
J Gastroenterol Hepatol., 35(7), 1208-1214, 01 Jul. 2020, Refereed

Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases.
Sugiura A (FA), Joshita S (CA), Yamashita Y, et al.
Biomedicines., 8(4), E74, 03 Apr. 2020, Refereed

Clinical In¬fluence of Hepatitis C Virus Eradication by Direct-acting Antivirals on Lipid Levels and “Ningen Dock” Health Check-up Categories in Patients with Chronic Hepatitis C Virus Infection
Joshita S (FA/CA), Sugiura A, Yamazaki T, et al.
Ningen Dock International., 7, 19-25, 01 Mar. 2020, Refereed

Virological Factors Associated With the Occurrence of Hepatitis B Virus (HBV) Reactivation in Patients With Resolved HBV Infection Analyzed Through Ultradeep Sequencing
Sakamoto K, Umemura T, Joshita S (5th), et al.
J Infect Dis., 221(3), 400-407, 14 Jan. 2020, Refereed

KIR/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis.
Umemura T, Joshita S (2nd), Saito H, Yoshizawa K, Norman GL, Tanaka E, Ota M.
JHEP Rep., 1(5), 353-360, 25 Oct. 2019, Refereed

Efficacy and safety of eradication therapy for elderly patients with helicobacter pylori infection
Kobayashi S (FA), Joshita S (CA), Yamamoto C, et al.
Medicine (Baltimore)., 98(30), e16619, 20 Jul. 2019, Refereed

Long-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitus
Fujimori N, Tanaka N, Joshita S (11th), et al.
Clin J Gastroenterol., 13(1), 83-89, 10 Jul. 2019, Refereed

Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis
Joshita S (FA/CA), Umemura T, Yamashita Y, et al.
Hepatol Res., 49(10), 1236-1243, 14 Jun. 2019, Refereed

Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis
Honda A, Tanaka A, Joshita S (15th), et al.
Hepatology., 70(6), 2035-2046, 12 Apr. 2019, Refereed

A Case of Adult T-Cell Leukemia/Lymphoma Complicated with Bilateral Chylothorax
Kako S (FA), Joshita S (CA), Matsuo A, et al.
Case Rep Oncol Med., 2019, 8357893, 17 Feb. 2019, Refereed

POGLUT1, the Putative Effector Gene Driven by rs2293370 in Primary Biliary Cholangitis Susceptibility Locus Chromosome 3q13.33
Hitomi Y, Ueno K, Joshita S (57th), et al.
Sci Rep., 9(1), 102, 14 Jan. 2019, Refereed

Improvement of porphyria cutanea tarda following treatment of hepatitis C virus by direct-acting antivirals: A case report.
Nihei T, Kiniwa Y, Joshita S (4th), et al.
J Dermatol., 46(5), E149-E151, 03 Nov. 2018, Refereed

Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C.
Umemura T, Yamazaki T, Joshita S (3rd), et al.
Cytokine., 111(1), 357-363, 05 Oct. 2018, Refereed

Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals.
Sugiura A (FA), Joshita S (FA), Umemura T (CA), et al.
J Viral Hepat., 25(12), 1462-1471, 30 Aug. 2018, Refereed

A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis.
Yamazaki T, Umemura T, Joshita S (3rd), et al.
Sci Rep., 8(1), 11924, 09 Aug. 2018, Refereed

Miglitol attenuates non-alcoholic steatohepatitis in diabetic patients.
Komatsu M, Tanaka N, Joshita S (10th), et al .
Hepatol Res., 48(13), 1092-1098, 27 Jul. 2018, Refereed

Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis.
Joshita S (FA), Umemura T (CA), Usami Y, et al.
Sci Rep., 8(1), 8159, 25 May 2018, Refereed

Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease.
Fujimori N, Umemura T, Joshita S (7th), et al.
World J Gastroenterol., 24(11), 1239-1249, 21 May 2018, Refereed

Salmonella Enteritidis cholecystitis with chronic granulomatous disease.
Yamashita Y, Kimura T, Joshita S (6th). et al.
IDCases., 12(1), 49-52, 14 May 2018, Refereed

KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients.
Saito H, Umemura T, Joshita S (3rd), et al.
Oncotarget., 9(28), 19650-19661, 13 Apr. 2018, Refereed

Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population.
Saito H, Hirayama A, Joshita S (4th), et al.
PLoS One., 13(4), e0195778, 12 Apr. 2018, Refereed

Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.
Kimura T, Tanaka N, Joshita S (6th), et al.
World J Gastroenterol., 24(13), 1440-1450, 07 Apr. 2018, Refereed

Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C.
Yamazaki T (FA), Joshita S (FA), Umemura T (CA), et al.
PLoS One., 13(4), e0195632, 04 Apr. 2018, Refereed

Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey.
Joshita S (FA), Yoshizawa K (CA), Umemura T, et al.
J Gastroenterol., 53(9), 1079-1088, 23 Feb. 2018, Refereed

Emergence of anti-mitochondrial M2 antibody in patient with angioimmunoblastic T-cell lymphoma.
Wakabayashi SI, Kimura T, Joshita S (4th), et al.
Clin J Gastroenterol., 11(4), 302-308, 10 Feb. 2018, Refereed

Two Cases of Primary Biliary Cholangitis with Hepatocellular Carcinoma in a Non-cirrhotic Stage
SUGIURA Ayumi, JOSHITA Satoru, YAMASHITA Yuki, KIMURA Takefumi, YAMAZAKI Tomoo, FUJIMORI Naoyuki, KOMATSU Michiharu, MATSUMOTO Akihiro, KOBAYASHI Shota, UMEMURA Takeji, TANAKA Eiji
The Shinshu Medical Journal, 66(1), 39-49, 10 Feb. 2018

Renal impairment is associated with increased risk of mortality in patients with cirrhosis: A retrospective cohort study
Umemura T, Joshita S (2nd), Shibata S, et al.
Medicine (Baltimore)., 98(6), e14475, 01 Feb. 2018, Refereed

Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development.
Vainchtein ID, Chin G, Joshita S (12th), et al.
Science., 359(6381), 1269-1273, 01 Feb. 2018, Refereed

Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism.
Song WM (FA), Joshita S (FA), Zhou Y, et al.
J Exp Med., 215(3), 745-760, 10 Jan. 2018, Refereed

A case of liver abscess co-infected with Desulfovibrio desulfuricans and Escherichia coli and review of the literature.
Yamazaki T (FA), Joshita S (CA), Kasuga E, et al.
J Infect Chemother., 24(5), 393-397, 18 Dec. 2017, Refereed

Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection.
Joshita S (FA), Ichikawa Y (FA), Umemura T (CA), et al.
Hepatol Res., 48(4), 275-285, 04 Dec. 2017, Refereed

Genetics and epigenetics in the pathogenesis of primary biliary cholangitis.
Joshita S (FA/CA), Umemura T, Tanaka E, Ota M.
Clin J Gastroenterol., 11(1), 11-18, 20 Nov. 2017, Refereed

Association of autoimmune hepatitis with Src homology 2 adaptor protein 3 gene polymorphisms in Japanese patients
Umemura T, Joshita S (2nd), Hamano H, et al.
J Hum Genet., 62(11), 963-967, 01 Nov. 2017, Refereed

Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury
Fujimori N, Komatsu M, Joshita S (13th), et al.
Clin J Gastroenterol., 10(5), 452-458, 01 Oct. 2017, Refereed

Association between lower air pressure and the onset of ischemic colitis: a case-control study
Kimura T, Akihiro S, Joshita S (7th), et al.
Eur J Gastroenterol Hepatol., 29(9), 1071-1078, 01 Sep. 2017, Refereed

Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis
Umemura T, Sekiguchi T, Joshita S (3rd), et al.
Liver Int., 37(6), 897-905, 01 Jun. 2017, Refereed

Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C
Yamazaki T (FA), Joshita S (FA), Umemura T (CA), et al.
Sci Rep., 20(7), 46705, 01 Apr. 2017, Refereed

Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection.
Kimura T, Kobayashi A, Joshita S (10th), et al.
Hepatol Res., 47(5), 405-418, 01 Apr. 2017, Refereed

A Patency Capsule Remained Intact in the Colon over 210 Hours.
Hihara Y, Joshita S (CA), Takahashi T, et al.
2017(2017), 1201404, 22 Feb. 2017, Refereed

Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population.
Kawashima M, Hitomi Y, Joshita S (33th), et al.
Hum Mol Genet., 26(3), 650-659, 01 Feb. 2017, Refereed

Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
Joshita S (FA/CA), Umemura T, Tanaka E, Ota M.
J Immunol Res., 2017, 3073504, 01 Feb. 2017, Refereed

Association between endotoxemia and histological features of nonalcoholic fatty liver disease
Kitabatake H, Tanaka N, Joshita S (12th), et al.
World J Gastroenterol., 23(4), 712-722, 28 Jan. 2017, Refereed

Lymphocyte Antigen 75 Polymorphisms Are Associated with Disease Susceptibility and Phenotype in Japanese Patients with Inflammatory Bowel Disease.
Hirayama A, Joshita S (CA), Kitahara K, et al.
Dis Markers., 2016(2016), 6485343, 14 Nov. 2016, Refereed

Incidence and prevalence of autoimmune hepatitis in the Ueda area, Japan.
Yoshizawa K, Joshita S (2nd), Matsumoto A, et al.
Hepatol Res, 46(9), 878-83, 01 Aug. 2016, Refereed

Liver stiffness-spleen size-to-platelet ratio risk score identifies esophageal varices in Japanese patients with chronic hepatitis C.
Shibata S, Umemura T, Joshita S (7th), et al.
Hepatol Res, 46(9), 884-9, 01 Aug. 2016, Refereed

Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease.
Shibata S (FA), Joshita S (FA), Umemura T (CA), et al.
Springerplus, 5(1), 998, 07 Jul. 2016, Refereed

Genetic Association of PTPN22 Polymorphisms with Autoimmune Hepatitis and Primary Biliary Cholangitis in Japan.
Umemura T, Joshita S (2nd), Yamazaki T, et al.
Sci Rep, 6, 29770, 11 Jun. 2016, Refereed

Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Ichikawa Y (FA), Joshita S (FA), Umemura T (CA), et al.
Hepatol Res., 47(2), 226-233, 22 Apr. 2016, Refereed

Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis.
Sekiguchi T, Umemura T, Joshita S (7th), et al.
PLOS ONE, 10(6), e0131658, 25 Jun. 2015, Refereed

Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis.
Umemura T (FA/CA), Joshita S (FA), Sekiguchi T, et al.
Am J Gastroenterol, 110(6), 857-64, 01 Jun. 2015, Refereed

Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα.
Komatsu M, Kimura T, Joshita S (9th), et al.
Biochim Biophys Acta, 1852(3), 473-81, 01 Mar. 2015, Refereed

AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosis.
Joshita S (FA/CA), Umemuta T, Ota M, Tanaka E.
J Hepatol., 61(6), 1443-5, 01 Dec. 2014, Refereed

Serum levels of interleukin-22 and hepatitis B core-related antigen are associated with treatment response to entecavir therapy in chronic hepatitis B.
Okuhara S, Umemura T, Joshita S (3rd), et al.
Hepatol Res., 44(10), E172-80, 01 Oct. 2014, Refereed

Characteristics and prediction of hepatitis B e-antigen negative hepatitis following seroconversion in patients with chronic hepatitis B.
Morita S, Matsumoto A, Joshita S (8th), et al.
Hepatol Res., 44(10), E45-53, 01 Oct. 2014, Refereed

KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C.
Umemura T, Ota M, Joshita S (11th), et al,.
Hum Immunol., 75(8), 822-6, 01 Aug. 2014, Refereed

Laparoscopic findings of congenital hepatic fibrosis: A case report and review of the published work.
Komatsu M, Tanaka N, Joshita S (7th), et al.
Hepatol Res., 44(7), 818-24, 01 Jul. 2014, Refereed

Human Leukocyte Antigen Class II Haplotypes Affect Clinical Characteristics and Progression of Type 1 Autoimmune Hepatitis in Japan
Umemura T, Katsuyama Y, Joshita S (5th), et al.
PLoS One., 9(6), e100565, 01 Jun. 2014, Refereed

STAT4 Gene Polymorphisms Are Associated with Susceptibility and ANA Status in Primary Biliary Cirrhosis
Joshita S (FA), Umemura T (CA), Makamura M, et al.
Dis Markers., 2014, 727393, 04 Feb. 2014, Refereed

Genetic polymorphism in IFNL4 and response to pegylated interferon-α and ribavirin in Japanese chronic hepatitis C patients.
Nozawa Y, Umemura Y, Joshita S (7th), et al.
Tissue Antigens., 83(1), 45-8, 01 Jan. 2014, Refereed

KIR, HLA, and IL28B variant predict response to antiviral therapy in genotype 1 chronic hepatitis C patients in Japan.
Nozawa Y, Umemura T, Joshita S (3rd), et al.
PLOS ONE, 8(12), e83381, 12 Dec. 2013, Refereed

Cutaneous sarcoidosis in a chronic hepatitis C patient receiving pegylated interferon and ribavirin therapy
Joshita S (FA/CA), Shirahata K, Yazaki Y, et al.
Hepatol Res., 43(7), 801-807, 15 May 2013, Refereed

Liver Dysfunction and Thrombocytopenia Diagnosed as Intravascular Large B-cell Lymphoma Using a Timely and Accurate Transjugular Liver Biopsy
Sekiguchi N, Joshita S (CA), Yoshida T, et al.
Intern Med., 52(17), 1903-1908, 01 Jan. 2013, Refereed

Association analysis of toll-like receptor 4 polymorphisms in Japanese primary biliary cirrhosis
Morita S (FA), Joshita S (FA), Umemura T (CA)m et al.
Hum Immunol., 74(2), 219-222, 01 Jan. 2013, Refereed

Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population
Nakamura M, Nishida N, Joshita S (42th), et al.
Am J Hum Genet., 91(4), 721-728, 20 Sep. 2012, Refereed

Super high resolution for single molecule-sequence-based typing of classical HLA loci at the 8-digit level using next generation sequencers
Shiina T, Suzuki S, Joshita S (9th), et al.
Tissue Antigens., 80(4), 305-316, 04 Aug. 2012, Refereed

Long-term outcome of japanese patients with type 1 autoimmune hepatitis
Yoshizawa K, Matsumoto A, Joshita S (5th), et al.
Hepatology., 56(2), 668-676, 06 Jul. 2012, Refereed

Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection
Matsumoto A, Tanaka E, Joshita S (LA), et al.
J Gastroenterol., 47(9), 1006-1013, 29 Feb. 2012, Refereed

Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection
Joshita S (FA), Umemura T, Katsuyama Y, et al.
Hum Immunol., 73(3), 298-300, 01 Jan. 2012, Refereed

Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis
Umemura T, Joshita S (2nd), Ichijo T, et al.
Hepatology., 55(2), 506-511, 19 Nov. 2011, Refereed

Serum interleukin (IL)-10 and IL-12 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C
Umemura T, Joshita S (2nd), Yoneda S, et al.
Antivir Ther., 16(7), 1073-1080, 01 Oct. 2011, Refereed

Early detection of interstitial pneumonia by monitoring KL-6 in a chronic hepatitis C patient undergoing pegylated interferon and ribavirin therapy
Ichikawa-Yamada Y, Joshita S (CA), Tsukahara Y, et al.
Hepatol Res., 41(9), 904-909, 01 Sep. 2011, Refereed

A Case of Pyogenic Liver Abscess Infected with Fusobacterium necrophorum Depicted by Microscopy and Confirmed by Tissue Culture
Nozawa Y, Joshita S (CA), Fukushima M, et al.
Intern Med., 50(17), 1815-1819, 01 Sep. 2011, Refereed

Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients
Aiba Y, Nakamura M, Joshita S (3rd), et al.
J Gastroenterol., 46(10), 1203-1212, 19 May 2011, Refereed

Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C
Yoneda S, Umemura T, Joshita S (3rd), et al.
Hepatol Res., 41(6), 587-593, 19 Apr. 2011, Refereed

Association of Serum Cytokine Levels With Treatment Response to Pegylated Interferon and Ribavirin Therapy in Genotype 1 Chronic Hepatitis C Patients
Yoneda S, Umemura T, Joshita S (5th), et al.
J Infect Dis., 203(8), 1087-1095, 11 Mar. 2011, Refereed

Cytokine profiles affecting the pathogenesis of autoimmune hepatitis in Japanese patients
Kamijo A, Yoshizawa K, Joshita S (3rd), et al.
Hepatol Res., 41(4), 350-357, 24 Feb. 2011, Refereed

Clinical significance of immunoglobulin G4-associated autoimmune hepatitis
Umemura T, Zen Y, Joshita S (4th), et al.
J Gastroenterol., 46 Suppl 1, 48-55, 01 Jan. 2011, Refereed

Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease
Hatta T, Fujinaga Y, Joshita S (10th), et al.
J Gastroenterol., 45(12), 1263-1271, 13 Jul. 2010, Refereed

Down-regulation of SREBP-1c is associated with the development of burned-out NASH.
Nagaya T, Tanaka N, Joshita S (9th), et al.
J Hepatol., 53(4), 724-31, 01 Jul. 2010, Refereed

A Patient with Advanced Hepatocellular Carcinoma Treated with Sorafenib Tosylate Showed Massive Tumor Lysis with Avoidance of Tumor Lysis syndrome
Joshita S (FA/CA), Yoshizawa K, Sano K, et al.
Intern Med, 49(11), 991-994, 01 Jun. 2010, Refereed

Serum Fragmented Cytokeratin 18 Levels Reflect the Histologic Activity Score of Nonalcoholic Fatty Liver Disease More Accurately Than Serum Alanine Aminotransferase Levels
Tsutsui M, Tanaka N, Joshita S (8th), et al.
J Clin Gastroenterol., 44(6), 440-447, 01 Jun. 2010, Refereed

Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients
Joshita S (FA), Umemura Takeji, Yoshizawa K, et al.
J Hepatol., 53(3), 537-541, 25 May 2010, Refereed

A2BP1 as a novel susceptible gene for primary biliary cirrhosis in Japanese patients
Joshita S (FA), Umemura T, Yoshizawa K, et al.
Hum Immunol, 71(5), 520-524, 06 May 2010, Refereed

A Case of Granulocyte-Colony Stimulating Factor-Producing Hepatocellular Carcinoma Confirmed by Immunohistochemistry
Joshita S (CA/FA), Nakazawa K, Koike S, et al.
J Korean Med Sci., 25(3), 476-480, 17 Feb. 2010, Refereed

Primitive Neuroectodermal Tumor as a Differential Diagnosis of CD56-Positive Tumors in Adults
Nagaya T, Tanaka N, Joshita S (4th), et al.
Intern Med, 48(15), 1267-1272, 03 Aug. 2009, Refereed

Granulocyte-Colony Stimulating Factor-Producing Pancreatic Adenosquamous Carcinoma Showing Aggressive Clinical Course
Joshita S (FA/CA), Nakazawa Koh, Sugiyama Y, et al.
Intern Med, 48(9), 687-691, 01 May 2009, Refereed

A case of well-differentiated cholangiolocellular carcinoma visualized with contrast-enhanced ultrasonography using Sonazoid
Joshita S (FA/CA), Ichijo T, Suzuki F, et al.
Hepatol Res, 39(2), 207-212, 01 Feb. 2009, Refereed

Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors.
Shirakawa H, Matsumoto A, Joshita S (3rd), et al.
Hepatolgy., 48(6), 1753-60, 01 Dec. 2008, Refereed

Development from simple steatosis to liver cirrhosis and hepatocellular carcinoma: a 27-year follow-up case.
Nagaya T, Tanaka N, Joshita S (7th), et al.
Clin J Gastroenterol., 1(3), 116-121, 01 Oct. 2008, Refereed

Zygomycosis presenting as acute myocardial infarction during hematological malignancies
Joshita S (FA/CA), Kitano K, Nagaya T, et al.
Intern Med., 47(9), 839-842, 01 May 2008, Refereed

Thrombotic thrombocytopenic purpura associated with pegylated-interferon alpha-2a by an ADAMTS13 inhibitor in a patient with chronic hepatitis C.
Kitano K, Gibo Y, Joshita S (6th), et al.
Haematologica., 91(8), ECR34, 01 Aug. 2006, Refereed